Durable Mechanical Circulatory Support: JACC Scientific Statement
Despite advances in medical therapy for patients with stage C heart failure (HF), survival for
patients with advanced HF is< 20% at 5 years. Durable left ventricular assist device (dLVAD) …
patients with advanced HF is< 20% at 5 years. Durable left ventricular assist device (dLVAD) …
[HTML][HTML] Pediatric ventricular assist device registries: update and perspectives in the era of miniaturized continuous-flow pumps
KM Lichtenstein, HP Tunuguntla, DM Peng… - Annals of …, 2021 - ncbi.nlm.nih.gov
The success of ventricular assist devices (VADs) in the treatment of end-stage heart failure
in the adult population has led to industrial innovation in VAD design, focusing on …
in the adult population has led to industrial innovation in VAD design, focusing on …
[HTML][HTML] JCS/JSCVS/JCC/CVIT 2023 guideline focused update on indication and operation of PCPS/ECMO/IMPELLA
T Nishimura, Y Hirata, T Ise, H Iwano, H Izutani… - Journal of …, 2024 - Elsevier
Mechanical circulatory support (MCS) plays a significant role as a therapeutic option for
severe heart failure, and its outcomes have been improving due to advancements in devices …
severe heart failure, and its outcomes have been improving due to advancements in devices …
Systemic ventricular assist device support in Fontan patients: a report by ACTION
BACKGROUND The size of the Fontan population with end-stage heart failure is growing. In
this population, heart transplantation has been the only option. This study sought to …
this population, heart transplantation has been the only option. This study sought to …
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the …
A Lorts, J Conway, M Schweiger, I Adachi… - The Journal of Heart …, 2021 - jhltonline.org
Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …
there is interest in understanding the optimal way to support these children with Ventricular …
Machine learning based on computational fluid dynamics enables geometric design optimisation of the NeoVAD blades
The NeoVAD is a proposed paediatric axial-flow Left Ventricular Assist Device (LVAD), small
enough to be implanted in infants. The design of the impeller and diffuser blades is …
enough to be implanted in infants. The design of the impeller and diffuser blades is …
The European Registry for patients with mechanical circulatory support (EUROMACS): third Paediatric (Paedi-EUROMACS) report
TMMH de By, M Schweiger, H Hussain… - European Journal of …, 2022 - academic.oup.com
OBJECTIVES A third paediatric report has been generated from the European Registry for
Patients with Mechanical Circulatory Support (EUROMACS). The purpose of EUROMACS …
Patients with Mechanical Circulatory Support (EUROMACS). The purpose of EUROMACS …
Waitlist outcomes for children with congenital heart disease: lessons learned from over 5000 heart transplant listings in the United States
M Townsend, T Karamlou, G Boyle, K Daly… - Journal of cardiac …, 2022 - Elsevier
Background We evaluated the impact of pediatric heart-allocation policy changes over time
and the approval of the Berlin ventricular assist device (VAD) on waitlist (WL) outcomes for …
and the approval of the Berlin ventricular assist device (VAD) on waitlist (WL) outcomes for …
An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular …
IB Hollis, DL Jennings, S Krim, VK Ton… - The Journal of Heart and …, 2024 - Elsevier
Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-
LVAD) continues to increase. Despite significant improvements in the delivery of care for …
LVAD) continues to increase. Despite significant improvements in the delivery of care for …
Current and future drug and device therapies for pediatric heart failure patients: potential lessons from adult trials
This review discusses the potential drug and device therapies for pediatric heart failure (HF)
due to reduced systolic function. It is important to realize that most drugs that are used in …
due to reduced systolic function. It is important to realize that most drugs that are used in …